{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T14:17:37Z","timestamp":1794838657321,"version":"4.9.1"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T00:00:00Z","timestamp":1675987200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T00:00:00Z","timestamp":1675987200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82160304"],"award-info":[{"award-number":["82160304"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32060180"],"award-info":[{"award-number":["32060180"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81860644"],"award-info":[{"award-number":["81860644"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81560596"],"award-info":[{"award-number":["81560596"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017720","name":"Kunming Science and Technology Bureau","doi-asserted-by":"publisher","award":["2019FE001 (-002)"],"award-info":[{"award-number":["2019FE001 (-002)"]}],"id":[{"id":"10.13039\/100017720","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017720","name":"Kunming Science and Technology Bureau","doi-asserted-by":"publisher","award":["2017FE467 (-001)"],"award-info":[{"award-number":["2017FE467 (-001)"]}],"id":[{"id":"10.13039\/100017720","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The Bacillus Calmette-Gu\u00e9rin (BCG) vaccine was discovered a century ago and has since been clinically applicable. BCG can not only be used for the prevention of tuberculosis, but also has a non-specific protective effect on the human body called trained immunity that is mediated by innate immune cells such as monocytes, macrophages, and natural killer cells. Mechanisms of trained immunity include epigenetic reprogramming, metabolic reprogramming, and long-term protection mediated by hematopoietic stem cells. Trained immunity has so far shown beneficial effects on cancer, viral-infections, autoimmune diseases, and a variety of other diseases, especially bladder cancer, respiratory viruses, and type 1 diabetes. The modulation of the immune response by BCG has led to the development of a variety of recombinant vaccines. Although the specific mechanism of BCG prevention on diseases has not been fully clarified, the potential role of BCG deserves further exploration, which is of great significance for prevention and treatment of diseases.<\/jats:p>","DOI":"10.1186\/s12967-023-03944-8","type":"journal-article","created":{"date-parts":[[2023,2,10]],"date-time":"2023-02-10T09:04:19Z","timestamp":1676019859000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":167,"title":["BCG-induced trained immunity: history, mechanisms and potential applications"],"prefix":"10.1186","volume":"21","author":[{"given":"Jingjing","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinya","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meixiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieqin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingxue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aihua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2652-6660","authenticated-orcid":false,"given":"Fukai","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,10]]},"reference":[{"issue":"7","key":"3944_CR1","doi-asserted-by":"publisher","first-page":"843","DOI":"10.2105\/AJPH.18.7.843-b","volume":"18","author":"SA Petroff","year":"1928","unstructured":"Petroff SA, Branch A. Bacillus calmette-gu\u00e9rin (BCG): animal experimentation and prophylactic immunization of children. Am J Public Health Nations Health. 1928;18(7):843\u201364.","journal-title":"Am J Public Health Nations Health"},{"issue":"6","key":"3944_CR2","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/s41577-020-0285-6","volume":"20","author":"MG Netea","year":"2020","unstructured":"Netea MG, Dom\u00ednguez-Andr\u00e9s J, Barreiro LB, Chavakis T, Divangahi M, Fuchs E, Joosten LAB, van der Meer JWM, Mhlanga MM, Mulder WJM, et al. Defining trained immunity and its role in health and disease. Nat Rev Immunol. 2020;20(6):375\u201388.","journal-title":"Nat Rev Immunol"},{"issue":"6284","key":"3944_CR3","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1126\/science.aaf1098","volume":"352","author":"MG Netea","year":"2016","unstructured":"Netea MG, Joosten LA, Latz E, Mills KH, Natoli G, Stunnenberg HG, O\u2019Neill LA, Xavier RJ. Trained immunity: a program of innate immune memory in health and disease. Science. 2016;352(6284):1098.","journal-title":"Science"},{"issue":"8","key":"3944_CR4","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.2105\/AJPH.18.8.1075-a","volume":"18","author":"M Ravenel","year":"1928","unstructured":"Ravenel M. La vaccination pr\u00e9ventive contre la tuberculose par le \u201cBCG.\u201d Am Publ Health Assoc. 1928;18(8):1075.","journal-title":"Am Publ Health Assoc"},{"issue":"1","key":"3944_CR5","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3181\/00379727-26-4143","volume":"26","author":"R Pearl","year":"1928","unstructured":"Pearl R. On the pathological relations between cancer and tuberculosis. Proc Soc Exp Biol Med. 1928;26(1):73\u20135.","journal-title":"Proc Soc Exp Biol Med"},{"key":"3944_CR6","first-page":"517","volume":"53","author":"MI Levine","year":"1946","unstructured":"Levine MI, Sackett MF. Results of BCG immunization in New York City. Am Rev Tuberc. 1946;53:517\u201332.","journal-title":"Am Rev Tuberc"},{"issue":"1","key":"3944_CR7","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S0041-3879(49)80055-9","volume":"30","author":"RG Ferguson","year":"1949","unstructured":"Ferguson RG, Simes AB. BCG vaccination of Indian infants in Saskatchewan. Tubercle. 1949;30(1):5\u201311.","journal-title":"Tubercle"},{"key":"3944_CR8","first-page":"690","volume":"84","author":"SR Rosenthal","year":"1961","unstructured":"Rosenthal SR, Loewinsohn E, Graham ML, Liveright D, Thorne MG, Johnson V. BCG vaccination in tuberculous households. Am Rev Respir Dis. 1961;84:690\u2013704.","journal-title":"Am Rev Respir Dis"},{"issue":"1","key":"3944_CR9","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1084\/jem.120.1.105","volume":"120","author":"GB Mackaness","year":"1964","unstructured":"Mackaness GB. The immunological basis of acquired cellular resistance. J Exp Med. 1964;120(1):105\u201320.","journal-title":"J Exp Med"},{"issue":"5","key":"3944_CR10","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1084\/jem.129.5.973","volume":"129","author":"GB Mackaness","year":"1969","unstructured":"Mackaness GB. The influence of immunologically committed lymphoid cells on macrophage activity in vivo. J Exp Med. 1969;129(5):973\u201392.","journal-title":"J Exp Med"},{"issue":"5541","key":"3944_CR11","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/259309a0","volume":"259","author":"IA Clark","year":"1976","unstructured":"Clark IA, Allison AC, Cox FE. Protection of mice against babesia and plasmodium with BCG. Nature. 1976;259(5541):309\u201311.","journal-title":"Nature"},{"issue":"5","key":"3944_CR12","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1093\/infdis\/137.5.550","volume":"137","author":"RH Civil","year":"1978","unstructured":"Civil RH, Warren KS, Mahmoud AA. Conditions for bacille calmette-gu\u00e9rin-induced resistance to infection with schistosoma mansoni in mice. J Infect Dis. 1978;137(5):550\u20135.","journal-title":"J Infect Dis"},{"issue":"5","key":"3944_CR13","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1080\/02681218880000401","volume":"26","author":"F Bistoni","year":"1988","unstructured":"Bistoni F, Verducci G, Perito S, Vecchiarelli A, Puccetti P, Marconi P, Cassone A. Immunomodulation by a low-virulence, agerminative variant of candida albicans further evidence for macrophage activation as one of the effector mechanisms of nonspecific anti-infectious protection. J Med Vet Mycol. 1988;26(5):285\u201399.","journal-title":"J Med Vet Mycol"},{"key":"3944_CR14","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1016\/S0264-410X(03)00181-6","volume":"21","author":"ML Garly","year":"2003","unstructured":"Garly ML, Martins CL, Bal\u00e9 C, Bald\u00e9 MA, Hedegaard KL, Gustafson P, Lisse IM, Whittle HC, Aaby P. BCG scar and positive tuberculin reaction associated with reduced child mortality in West Africa a non-specific beneficial effect of BCG. Vaccine. 2003;21:2782\u201390.","journal-title":"Vaccine"},{"issue":"5","key":"3944_CR15","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.chom.2011.04.006","volume":"9","author":"MG Netea","year":"2011","unstructured":"Netea MG, Quintin J, van der Meer JW. Trained immunity: a memory for innate host defense. Cell Host Microbe. 2011;9(5):355\u201361.","journal-title":"Cell Host Microbe"},{"issue":"43","key":"3944_CR16","doi-asserted-by":"publisher","first-page":"17537","DOI":"10.1073\/pnas.1202870109","volume":"109","author":"J Kleinnijenhuis","year":"2012","unstructured":"Kleinnijenhuis J, Quintin J, Preijers F, Joosten LA, Ifrim DC, Saeed S, Jacobs C, van Loenhout J, de Jong D, Stunnenberg HG, et al. Bacille calmette-guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes. Proc Natl Acad Sci USA. 2012;109(43):17537\u201342.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6204","key":"3944_CR17","doi-asserted-by":"publisher","first-page":"1251086","DOI":"10.1126\/science.1251086","volume":"345","author":"S Saeed","year":"2014","unstructured":"Saeed S, Quintin J, Kerstens HH, Rao NA, Aghajanirefah A, Matarese F, Cheng SC, Ratter J, Berentsen K, van der Ent MA, et al. Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity. Science. 2014;345(6204):1251086.","journal-title":"Science"},{"key":"3944_CR18","doi-asserted-by":"publisher","DOI":"10.1126\/science.1250684","author":"S-c Cheng","year":"2014","unstructured":"Cheng S-c, Quintin J, Cramer R, Shepardson K, Saeed S, Kumar V, Giamarellos-Bourboulis E, Martens J, Rao N, Aghajanirefah A, et al. MTOR- and HIF-1\u03b1-mediated aerobic glycolysis as metabolic basis for trained immunity. Science. 2014. https:\/\/doi.org\/10.1126\/science.1250684.","journal-title":"Science"},{"issue":"10","key":"3944_CR19","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1016\/j.celrep.2016.11.011","volume":"17","author":"RJW Arts","year":"2016","unstructured":"Arts RJW, Carvalho A, La Rocca C, Palma C, Rodrigues F, Silvestre R, Kleinnijenhuis J, Lachmandas E, Goncalves LG, Belinha A, et al. Immunometabolic pathways in BCG-induced trained immunity. Cell Rep. 2016;17(10):2562\u201371.","journal-title":"Cell Rep"},{"issue":"1\u20132","key":"3944_CR20","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.cell.2017.11.034","volume":"172","author":"I Mitroulis","year":"2018","unstructured":"Mitroulis I, Ruppova K, Wang B, Chen LS, Grzybek M, Grinenko T, Eugster A, Troullinaki M, Palladini A, Kourtzelis I, et al. Modulation of myelopoiesis progenitors is an integral component of trained immunity. Cell. 2018;172(1\u20132):147-161.e12.","journal-title":"Cell"},{"issue":"1\u20132","key":"3944_CR21","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.cell.2017.12.031","volume":"172","author":"E Kaufmann","year":"2018","unstructured":"Kaufmann E, Sanz J, Dunn JL, Khan N, Mendonca LE, Pacis A, Tzelepis F, Pernet E, Dumaine A, Grenier JC, et al. BCG educates hematopoietic stem cells to generate protective innate immunity against tuberculosis. Cell. 2018;172(1\u20132):176\u201390.","journal-title":"Cell"},{"issue":"1","key":"3944_CR22","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/trstmh\/tru168","volume":"109","author":"J Kleinnijenhuis","year":"2015","unstructured":"Kleinnijenhuis J, van Crevel R, Netea MG. Trained immunity: consequences for the heterologous effects of BCG vaccination. Trans R Soc Trop Med Hyg. 2015;109(1):29\u201335.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"7","key":"3944_CR23","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41577-019-0151-6","volume":"19","author":"Q Zhang","year":"2019","unstructured":"Zhang Q, Cao X. Epigenetic regulation of the innate immune response to infection. Nat Rev Immunol. 2019;19(7):417\u201332.","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"3944_CR24","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.1002\/jcp.24054","volume":"227","author":"DR Donohoe","year":"2012","unstructured":"Donohoe DR, Bultman SJ. Metaboloepigenetics: interrelationships between energy metabolism and epigenetic control of gene expression. J Cell Physiol. 2012;227(9):3169\u201377.","journal-title":"J Cell Physiol"},{"issue":"2","key":"3944_CR25","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.chom.2012.06.006","volume":"12","author":"J Quintin","year":"2012","unstructured":"Quintin J, Saeed S, Martens JHA, Giamarellos-Bourboulis EJ, Ifrim DC, Logie C, Jacobs L, Jansen T, Kullberg BJ, Wijmenga C, et al. Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes. Cell Host Microbe. 2012;12(2):223\u201332.","journal-title":"Cell Host Microbe"},{"issue":"2","key":"3944_CR26","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.clim.2014.10.005","volume":"155","author":"J Kleinnijenhuis","year":"2014","unstructured":"Kleinnijenhuis J, Quintin J, Preijers F, Joosten LA, Jacobs C, Xavier RJ, van der Meer JW, van Crevel R, Netea MG. BCG-induced trained immunity in NK cells: role for non-specific protection to infection. Clin Immunol. 2014;155(2):213\u20139.","journal-title":"Clin Immunol"},{"issue":"7164","key":"3944_CR27","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/nature06246","volume":"449","author":"R Medzhitov","year":"2007","unstructured":"Medzhitov R. Recognition of microorganisms and activation of the immune response. Nature. 2007;449(7164):819\u201326.","journal-title":"Nature"},{"issue":"1","key":"3944_CR28","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.chom.2017.12.010","volume":"23","author":"RJW Arts","year":"2018","unstructured":"Arts RJW, Moorlag S, Novakovic B, Li Y, Wang SY, Oosting M, Kumar V, Xavier RJ, Wijmenga C, Joosten LAB, et al. BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity. Cell Host Microbe. 2018;23(1):89-100.e5.","journal-title":"Cell Host Microbe"},{"issue":"7","key":"3944_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108387","volume":"33","author":"S Moorlag","year":"2020","unstructured":"Moorlag S, Rodriguez-Rosales YA, Gillard J, Fanucchi S, Theunissen K, Novakovic B, de Bont CM, Negishi Y, Fok ET, Kalafati L, et al. BCG vaccination induces long-term functional reprogramming of human neutrophils. Cell Rep. 2020;33(7): 108387.","journal-title":"Cell Rep"},{"issue":"1","key":"3944_CR30","doi-asserted-by":"publisher","first-page":"5670","DOI":"10.1038\/s41467-019-13636-x","volume":"10","author":"M Jeljeli","year":"2019","unstructured":"Jeljeli M, Riccio LGC, Doridot L, Ch\u00eane C, Nicco C, Chouzenoux S, Deletang Q, Allanore Y, Kavian N, Batteux F. Trained immunity modulates inflammation-induced fibrosis. Nat Commun. 2019;10(1):5670.","journal-title":"Nat Commun"},{"issue":"6","key":"3944_CR31","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/j.chom.2008.05.003","volume":"3","author":"KJ Ishii","year":"2008","unstructured":"Ishii KJ, Koyama S, Nakagawa A, Coban C, Akira S. Host innate immune receptors and beyond: making sense of microbial infections. Cell Host Microbe. 2008;3(6):352\u201363.","journal-title":"Cell Host Microbe"},{"issue":"2","key":"3944_CR32","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.chom.2020.05.014","volume":"28","author":"B Cirovic","year":"2020","unstructured":"Cirovic B, de Bree LCJ, Groh L, Blok BA, Chan J, van der Velden W, Bremmers MEJ, van Crevel R, Handler K, Picelli S, et al. BCG vaccination in humans elicits trained immunity via the hematopoietic progenitor compartment. Cell Host Microbe. 2020;28(2):322\u201334.","journal-title":"Cell Host Microbe"},{"issue":"5","key":"3944_CR33","first-page":"S1","volume":"20","author":"CA Dinarello","year":"2002","unstructured":"Dinarello CA. The IL-1 family and inflammatory diseases. Clin Exp Rheumatol. 2002;20(5):S1-13.","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"3944_CR34","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.immuni.2015.02.005","volume":"42","author":"AK Jha","year":"2015","unstructured":"Jha AK, Huang SC, Sergushichev A, Lampropoulou V, Ivanova Y, Loginicheva E, Chmielewski K, Stewart KM, Ashall J, Everts B, et al. Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization. Immunity. 2015;42(3):419\u201330.","journal-title":"Immunity"},{"issue":"12","key":"3944_CR35","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1128\/CVI.00349-16","volume":"23","author":"S Bekkering","year":"2016","unstructured":"Bekkering S, Blok BA, Joosten LA, Riksen NP, van Crevel R, Netea MG. In vitro experimental model of trained innate immunity in human primary monocytes. Clin Vaccine Immunol. 2016;23(12):926\u201333.","journal-title":"Clin Vaccine Immunol"},{"issue":"9517","key":"3944_CR36","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/S0140-6736(06)68507-3","volume":"367","author":"BB Trunz","year":"2006","unstructured":"Trunz BB, Fine P, Dye C. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet. 2006;367(9517):1173\u201380.","journal-title":"Lancet"},{"issue":"2","key":"3944_CR37","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1017\/S002217240006945X","volume":"87","author":"SJ Stanley","year":"1981","unstructured":"Stanley SJ, Howland C, Stone MM, Sutherland I. BCG vaccination of children against leprosy in uganda: final results. J Hyg (Lond). 1981;87(2):233\u201348.","journal-title":"J Hyg (Lond)"},{"issue":"4","key":"3944_CR38","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1093\/cid\/cit790","volume":"58","author":"P Mangtani","year":"2014","unstructured":"Mangtani P, Abubakar I, Ariti C, Beynon R, Pimpin L, Fine PE, Rodrigues LC, Smith PG, Lipman M, Whiting PF, et al. Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials. Clin Infect Dis. 2014;58(4):470\u201380.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"3944_CR39","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/184291a0","volume":"184","author":"LJ Old","year":"1959","unstructured":"Old LJ, Clarke DA, Benacerraf B. Effect of bacillus calmette-guerin infection on transplanted tumours in the mouse. Nature. 1959;184(5):291\u20132.","journal-title":"Nature"},{"issue":"6","key":"3944_CR40","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/j.urology.2005.12.014","volume":"67","author":"RF Han","year":"2006","unstructured":"Han RF, Pan JG. Can intravesical bacillus calmette-gu\u00e9rin reduce recurrence in patients with superficial bladder cancer? A meta-analysis of randomized trials. Urology. 2006;67(6):1216\u201323.","journal-title":"Urology"},{"issue":"2","key":"3944_CR41","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/S0022-5347(17)58737-6","volume":"116","author":"A Morales","year":"1976","unstructured":"Morales A, Eidinger D, Bruce A. Intracavitary bacillus calmette-guerin in the treatment of superficial bladder tumors. J Urol. 1976;116(2):180\u20133.","journal-title":"J Urol"},{"issue":"2","key":"3944_CR42","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/apm.13011","volume":"128","author":"ES Larsen","year":"2020","unstructured":"Larsen ES, Joensen UN, Poulsen AM, Goletti D, Johansen IS. Bacillus calmette-gu\u00e9rin immunotherapy for bladder cancer: a review of immunological aspects, clinical effects and BCG infections. APMIS. 2020;128(2):92\u2013103.","journal-title":"APMIS"},{"issue":"1","key":"3944_CR43","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s00520-021-06468-3","volume":"30","author":"M Miyake","year":"2022","unstructured":"Miyake M, Nishimura N, Oda Y, Owari T, Hori S, Morizawa Y, Gotoh D, Nakai Y, Anai S, Torimoto K, et al. Intravesical bacillus calmette-guerin treatment-induced sleep quality deterioration in patients with non-muscle invasive bladder cancer: functional outcome assessment based on a questionnaire survey and actigraphy. Support Care Cancer. 2022;30(1):887\u201395.","journal-title":"Support Care Cancer"},{"issue":"1","key":"3944_CR44","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1038\/s41467-022-28509-z","volume":"13","author":"AK Singh","year":"2022","unstructured":"Singh AK, Praharaj M, Lombardo KA, Yoshida T, Matoso A, Baras AS, Zhao L, Srikrishna G, Huang J, Prasad P, et al. Re-engineered BCG overexpressing cyclic di-AMP augments trained immunity and exhibits improved efficacy against bladder cancer. Nat Commun. 2022;13(1):878.","journal-title":"Nat Commun"},{"issue":"3","key":"3944_CR45","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1046\/j.1523-1747.2002.00643.x","volume":"119","author":"A Pfahlberg","year":"2002","unstructured":"Pfahlberg A, K\u00f6lmel KF, Grange JM, Mastrangelo G, Krone B, Botev IN, Niin M, Seebacher C, Lambert D, Shafir R, et al. Inverse association between melanoma and previous vaccinations against tuberculosis and smallpox: results of the FEBIM study. J Invest Dermatol. 2002;119(3):570\u20135.","journal-title":"J Invest Dermatol"},{"issue":"2","key":"3944_CR46","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.urolonc.2020.09.031","volume":"39","author":"JP Sfakianos","year":"2021","unstructured":"Sfakianos JP, Salome B, Daza J, Farkas A, Bhardwaj N, Horowitz A. Bacillus calmette-guerin (BCG): Its fight against pathogens and cancer. Urol Oncol. 2021;39(2):121\u20139.","journal-title":"Urol Oncol"},{"issue":"6","key":"3944_CR47","doi-asserted-by":"publisher","first-page":"11","DOI":"10.14715\/cmb\/2018.64.6.3","volume":"64","author":"K Yao","year":"2018","unstructured":"Yao K, Wang W, Li H, Lin J, Tan W, Chen Y, Guo L, Lin D, Chen T, Zhou J, et al. Bacillus calmette gu\u00e9rin (BCG) activates lymphocyte to promote autophagy and apoptosis of gastric cancer MGC-803 cell. Cell Mol Biol. 2018;64(6):11\u20136.","journal-title":"Cell Mol Biol"},{"issue":"9","key":"3944_CR48","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.12014","volume":"2","author":"NT Usher","year":"2019","unstructured":"Usher NT, Chang S, Howard RS, Martinez A, Harrison LH, Santosham M, Aronson NE. Association of BCG vaccination in childhood with subsequent cancer diagnoses: a 60-year follow-up of a clinical trial. JAMA Netw Open. 2019;2(9): e1912014.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"3944_CR49","doi-asserted-by":"publisher","first-page":"15986","DOI":"10.1038\/s41598-017-16067-0","volume":"7","author":"M Morra","year":"2017","unstructured":"Morra M, Kien N, Elmaraezy A, Abdelaziz O, Elsayed A, Halhouli O, Montasr A, Vu T, Ho C, Foly A, et al. Early vaccination protects against childhood leukemia: a systematic review and meta-analysis. Sci Rep. 2017;7(1):15986.","journal-title":"Sci Rep"},{"issue":"3","key":"3944_CR50","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1097\/INF.0b013e3182458289","volume":"31","author":"S Biering-S\u00f8rensen","year":"2012","unstructured":"Biering-S\u00f8rensen S, Aaby P, Napirna BM, Roth A, Ravn H, Rodrigues A, Whittle H, Benn CS. Small randomized trial among low-birth-weight children receiving bacillus calmette-gu\u00e9rin vaccination at first health center contact. Pediatr Infect Dis J. 2012;31(3):306\u20138.","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"3944_CR51","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/j.1464-410X.2012.11754.x","volume":"112","author":"NM Gandhi","year":"2013","unstructured":"Gandhi NM, Morales A, Lamm DL. Bacillus calmette-gu\u00e9rin immunotherapy for genitourinary cancer. BJU Int. 2013;112(3):288\u201397.","journal-title":"BJU Int"},{"issue":"3","key":"3944_CR52","first-page":"185","volume":"43","author":"DE Wardhana","year":"2011","unstructured":"Wardhana DE, Sultana A, Mandang V, Jim E. The efficacy of bacillus calmette-guerin vaccinations for the prevention of acute upper respiratory tract infection in the elderly. Acta Medica Indonesiana. 2011;43(3):185\u201390.","journal-title":"Acta Medica Indonesiana"},{"issue":"12","key":"3944_CR53","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1016\/j.cmi.2019.04.020","volume":"25","author":"S Moorlag","year":"2019","unstructured":"Moorlag S, Arts RJW, van Crevel R, Netea MG. Non-specific effects of BCG vaccine on viral infections. Clin Microbiol Infect. 2019;25(12):1473\u20138.","journal-title":"Clin Microbiol Infect"},{"issue":"12","key":"3944_CR54","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1093\/infdis\/jiv332","volume":"212","author":"J Leentjens","year":"2015","unstructured":"Leentjens J, Kox M, Stokman R, Gerretsen J, Diavatopoulos DA, van Crevel R, Rimmelzwaan GF, Pickkers P, Netea MG. BCG vaccination enhances the immunogenicity of subsequent influenza vaccination in healthy volunteers: a randomized, placebo-controlled pilot study. J Infect Dis. 2015;212(12):1930\u20138.","journal-title":"J Infect Dis"},{"key":"3944_CR55","first-page":"31","volume":"1","author":"DH Libraty","year":"2014","unstructured":"Libraty DH, Zhang L, Woda M, Acosta LP, Obcena A, Brion JD, Capeding RZ. Neonatal BCG vaccination is associated with enhanced T-helper 1 immune responses to heterologous infant vaccines. Trials Vaccinol. 2014;1:31\u20135.","journal-title":"Trials Vaccinol"},{"issue":"1","key":"3944_CR56","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s00253-021-11682-4","volume":"106","author":"QJ Xue","year":"2022","unstructured":"Xue QJ, Yu HX, Liu A, Wang H, Li YQ, Chen T, Wang QL. The inhibitory effect of rBCG on EB virus-positive tumours using an EB virus fusion gene. Appl Microbiol Biotechnol. 2022;106(1):185\u201395.","journal-title":"Appl Microbiol Biotechnol"},{"issue":"1","key":"3944_CR57","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/j.1525-1470.2012.01848.x","volume":"30","author":"A Salem","year":"2013","unstructured":"Salem A, Nofal A, Hosny D. Treatment of common and plane warts in children with topical viable bacillus calmette-guerin. Pediatr Dermatol. 2013;30(1):60\u20133.","journal-title":"Pediatr Dermatol"},{"issue":"3","key":"3944_CR58","doi-asserted-by":"publisher","first-page":"411","DOI":"10.4103\/0378-6323.193623","volume":"83","author":"I Podder","year":"2017","unstructured":"Podder I, Bhattacharya S, Mishra V, Sarkar TK, Chandra S, Sil A, Pal S, Kumar D, Saha A, Shome K, et al. Immunotherapy in viral warts with intradermal bacillus calmette-guerin vaccine versus intradermal tuberculin purified protein derivative: a double-blind, randomized controlled trial comparing effectiveness and safety in a tertiary care center in Eastern India. Indian J Dermatol Venereol Leprol. 2017;83(3):411.","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"1","key":"3944_CR59","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1212\/01.wnl.0000438216.93319.ab","volume":"82","author":"G Ristori","year":"2014","unstructured":"Ristori G, Romano S, Cannoni S, Visconti A, Tinelli E, Mendozzi L, Cecconi P, Lanzillo R, Quarantelli M, Buttinelli C, et al. Effects of bacille calmette-guerin after the first demyelinating event in the CNS. Neurology. 2014;82(1):41\u20138.","journal-title":"Neurology"},{"key":"3944_CR60","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00970","author":"C Covian","year":"2020","unstructured":"Covian C, Retamal-Diaz A, Bueno SM, Kalergis AM. Could BCG vaccination induce protective trained immunity for SARS-CoV-2? Front Immunol. 2020. https:\/\/doi.org\/10.3389\/fimmu.2020.00970.","journal-title":"Front Immunol"},{"issue":"32","key":"3944_CR61","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1126\/sciadv.abc1463","volume":"6","author":"MK Berg","year":"2020","unstructured":"Berg MK, Yu Q, Salvador CE, Melani I, Kitayama S. Mandated bacillus calmette-gu\u00e9rin (BCG) vaccination predicts flattened curves for the spread of COVID-19. Sci Adv. 2020;6(32):1463.","journal-title":"Sci Adv"},{"issue":"41","key":"3944_CR62","doi-asserted-by":"publisher","first-page":"25203","DOI":"10.1073\/pnas.2016733117","volume":"117","author":"CS Lindestam Arlehamn","year":"2020","unstructured":"Lindestam Arlehamn CS, Sette A, Peters B. Lack of evidence for BCG vaccine protection from severe COVID-19. Proc Natl Acad Sci USA. 2020;117(41):25203\u20134.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3944_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-018-0062-8","author":"WM K\u00fchtreiber","year":"2018","unstructured":"K\u00fchtreiber WM, Tran L, Kim T, Dybala M, Nguyen B, Plager S, Huang D, Janes S, Defusco A, Baum D, et al. Long-term reduction in hyperglycemia in advanced type 1 diabetes: the value of induced aerobic glycolysis with BCG vaccinations. NPJ Vaccines. 2018. https:\/\/doi.org\/10.1038\/s41541-018-0062-8.","journal-title":"NPJ Vaccines"},{"key":"3944_CR64","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/j.1749-6632.2002.tb02990.x","volume":"958","author":"CB Sanjeevi","year":"2002","unstructured":"Sanjeevi CB, Das AK, Shtauvere-Brameus A. BCG vaccination and GAD65 and IA-2 autoantibodies in autoimmune diabetes in southern India. Ann N Y Acad Sci. 2002;958:293\u20136.","journal-title":"Ann N Y Acad Sci"},{"issue":"9","key":"3944_CR65","doi-asserted-by":"publisher","first-page":"6201","DOI":"10.4049\/jimmunol.181.9.6201","volume":"181","author":"J Lee","year":"2008","unstructured":"Lee J, Reinke EK, Zozulya AL, Sandor M, Fabry Z. Mycobacterium bovis bacille calmette-gu\u00e9rin infection in the CNS suppresses experimental autoimmune encephalomyelitis and Th17 responses in an IFN-gamma-independent manner. J Immunol. 2008;181(9):6201\u201312.","journal-title":"J Immunol"},{"issue":"8","key":"3944_CR66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0041756","volume":"7","author":"DL Faustman","year":"2012","unstructured":"Faustman DL, Wang L, Okubo Y, Burger D, Ban L, Man G, Zheng H, Schoenfeld D, Pompei R, Avruch J, et al. Proof-of-concept, randomized, controlled clinical trial of bacillus-calmette-guerin for treatment of long-term type 1 diabetes. PLoS ONE. 2012;7(8): e41756.","journal-title":"PLoS ONE"},{"issue":"3","key":"3944_CR67","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1067\/mai.2003.171","volume":"111","author":"GB Marks","year":"2003","unstructured":"Marks GB, Ng K, Zhou J, Toelle BG, Xuan W, Belousova EG, Britton WJ. The effect of neonatal BCG vaccination on atopy and asthma at age 7 to 14 years: an historical cohort study in a community with a very low prevalence of tuberculosis infection and a high prevalence of atopic disease. J Allergy Clin Immunol. 2003;111(3):541\u20139.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"3944_CR68","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.jaci.2010.07.039","volume":"127","author":"DL Arnoldussen","year":"2011","unstructured":"Arnoldussen DL, Linehan M, Sheikh A. BCG vaccination and allergy: a systematic review and meta-analysis. J Allergy Clin Immunol. 2011;127(1):246\u201353.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"3944_CR69","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1093\/ije\/dyp307","volume":"39","author":"M El-Zein","year":"2010","unstructured":"El-Zein M, Parent ME, Benedetti A, Rousseau MC. Does BCG vaccination protect against the development of childhood asthma? A systematic review and meta-analysis of epidemiological studies. Int J Epidemiol. 2010;39(2):469\u201386.","journal-title":"Int J Epidemiol"},{"issue":"5","key":"3944_CR70","doi-asserted-by":"publisher","first-page":"491","DOI":"10.3390\/vaccines9050491","volume":"9","author":"D Klinger","year":"2021","unstructured":"Klinger D, Hill BL, Barda N, Halperin E, Gofrit ON, Greenblatt CL, Rappoport N, Linial M, Bercovier H. Bladder cancer immunotherapy by BCG is associated with a significantly reduced risk of Alzheimer\u2019s disease and Parkinson\u2019s disease. Vaccines. 2021;9(5):491.","journal-title":"Vaccines"},{"issue":"1","key":"3944_CR71","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1038\/s41467-019-08659-3","volume":"10","author":"J Walk","year":"2019","unstructured":"Walk J, de Bree LCJ, Graumans W, Stoter R, van Gemert GJ, van de Vegte-Bolmer M, Teelen K, Hermsen CC, Arts RJW, Behet MC, et al. Outcomes of controlled human malaria infection after BCG vaccination. Nat Commun. 2019;10(1):874.","journal-title":"Nat Commun"},{"issue":"4","key":"3944_CR72","doi-asserted-by":"publisher","first-page":"745","DOI":"10.3390\/vaccines8040745","volume":"8","author":"J Witschkowski","year":"2020","unstructured":"Witschkowski J, Behrends J, Frank R, Eggers L, von Borstel L, Hertz D, Mueller AK, Schneider BE. BCG provides short-term protection from experimental cerebral malaria in mice. Vaccines. 2020;8(4):745.","journal-title":"Vaccines"},{"issue":"2","key":"3944_CR73","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.1365-3156.2006.01766.x","volume":"12","author":"A Rodrigues","year":"2007","unstructured":"Rodrigues A, Schellenberg JA, Roth A, Benn CS, Aaby P, Greenwood B. Revaccination with bacillus calmette-guerin (BCG) vaccine does not reduce morbidity from malaria in African children. Trop Med Int Health. 2007;12(2):224\u20139.","journal-title":"Trop Med Int Health"},{"key":"3944_CR74","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1016\/j.cell.2022.03.043","volume":"185","author":"X Li","year":"2022","unstructured":"Li X, Wang H, Yu X, Saha G, Kalafati L, Ioannidis C, Mitroulis I, Netea MG, Chavakis T, Hajishengallis G. Maladaptive innate immune training of myelopoiesis links inflammatory comorbidities. Cell. 2022;185:1709\u201327.","journal-title":"Cell"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-03944-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-023-03944-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-03944-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T12:26:25Z","timestamp":1701865585000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-023-03944-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,10]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3944"],"URL":"https:\/\/doi.org\/10.1186\/s12967-023-03944-8","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,10]]},"assertion":[{"value":"3 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"We declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"106"}}